ARCOSA INC (ACA) Stock Fundamental Analysis

NYSE:ACA • US0396531008

127.47 USD
+0.75 (+0.59%)
At close: Feb 13, 2026
127.47 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ACA. ACA was compared to 55 industry peers in the Construction & Engineering industry. ACA has only an average score on both its financial health and profitability. ACA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year ACA was profitable.
  • In the past year ACA had a positive cash flow from operations.
  • Each year in the past 5 years ACA has been profitable.
  • Each year in the past 5 years ACA had a positive operating cash flow.
ACA Yearly Net Income VS EBIT VS OCF VS FCFACA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

  • ACA has a Return On Assets (2.94%) which is comparable to the rest of the industry.
  • ACA has a Return On Equity of 5.75%. This is in the lower half of the industry: ACA underperforms 61.82% of its industry peers.
  • ACA's Return On Invested Capital of 4.99% is in line compared to the rest of the industry. ACA outperforms 43.64% of its industry peers.
  • ACA had an Average Return On Invested Capital over the past 3 years of 3.99%. This is significantly below the industry average of 16.92%.
  • The 3 year average ROIC (3.99%) for ACA is below the current ROIC(4.99%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.94%
ROE 5.75%
ROIC 4.99%
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ACA Yearly ROA, ROE, ROICACA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • ACA has a Profit Margin (5.25%) which is in line with its industry peers.
  • ACA's Profit Margin has declined in the last couple of years.
  • With a decent Operating Margin value of 10.27%, ACA is doing good in the industry, outperforming 69.09% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ACA has declined.
  • ACA has a better Gross Margin (21.61%) than 67.27% of its industry peers.
  • In the last couple of years the Gross Margin of ACA has remained more or less at the same level.
Industry RankSector Rank
OM 10.27%
PM (TTM) 5.25%
GM 21.61%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
ACA Yearly Profit, Operating, Gross MarginsACA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACA is destroying value.
  • ACA has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ACA has more shares outstanding
  • Compared to 1 year ago, ACA has a worse debt to assets ratio.
ACA Yearly Shares OutstandingACA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ACA Yearly Total Debt VS Total AssetsACA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • ACA has an Altman-Z score of 2.66. This is not the best score and indicates that ACA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ACA (2.66) is comparable to the rest of the industry.
  • ACA has a debt to FCF ratio of 5.03. This is a neutral value as ACA would need 5.03 years to pay back of all of its debts.
  • ACA has a better Debt to FCF ratio (5.03) than 63.64% of its industry peers.
  • ACA has a Debt/Equity ratio of 0.61. This is a neutral value indicating ACA is somewhat dependend on debt financing.
  • ACA has a Debt to Equity ratio (0.61) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.03
Altman-Z 2.66
ROIC/WACC0.54
WACC9.22%
ACA Yearly LT Debt VS Equity VS FCFACA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 2.02 indicates that ACA has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 2.02, ACA belongs to the best of the industry, outperforming 87.27% of the companies in the same industry.
  • ACA has a Quick Ratio of 1.30. This is a normal value and indicates that ACA is financially healthy and should not expect problems in meeting its short term obligations.
  • ACA has a Quick ratio (1.30) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.3
ACA Yearly Current Assets VS Current LiabilitesACA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 17.03% over the past year.
  • Measured over the past 5 years, ACA shows a small growth in Earnings Per Share. The EPS has been growing by 5.16% on average per year.
  • Looking at the last year, ACA shows a quite strong growth in Revenue. The Revenue has grown by 13.96% in the last year.
  • ACA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.15% yearly.
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%

3.2 Future

  • ACA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.76% yearly.
  • ACA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.15% yearly.
EPS Next Y41.62%
EPS Next 2Y26.58%
EPS Next 3Y21.76%
EPS Next 5YN/A
Revenue Next Year10.81%
Revenue Next 2Y8.17%
Revenue Next 3Y7.15%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ACA Yearly Revenue VS EstimatesACA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
ACA Yearly EPS VS EstimatesACA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 33.72, which means the current valuation is very expensive for ACA.
  • 61.82% of the companies in the same industry are more expensive than ACA, based on the Price/Earnings ratio.
  • ACA is valuated rather expensively when we compare the Price/Earnings ratio to 26.68, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 26.43, the valuation of ACA can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ACA indicates a somewhat cheap valuation: ACA is cheaper than 72.73% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. ACA is around the same levels.
Industry RankSector Rank
PE 33.72
Fwd PE 26.43
ACA Price Earnings VS Forward Price EarningsACA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ACA is valued a bit cheaper than the industry average as 74.55% of the companies are valued more expensively.
  • 80.00% of the companies in the same industry are more expensive than ACA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.87
EV/EBITDA 14.72
ACA Per share dataACA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ACA's earnings are expected to grow with 21.76% in the coming years.
PEG (NY)0.81
PEG (5Y)6.53
EPS Next 2Y26.58%
EPS Next 3Y21.76%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • ACA has a yearly dividend return of 0.16%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.14, ACA pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.84, ACA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.16%

5.2 History

  • The dividend of ACA decreases each year by -0.48%.
  • ACA has been paying a dividend for over 5 years, so it has already some track record.
  • ACA has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-0.48%
Div Incr Years0
Div Non Decr Years5
ACA Yearly Dividends per shareACA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • 6.66% of the earnings are spent on dividend by ACA. This is a low number and sustainable payout ratio.
DP6.66%
EPS Next 2Y26.58%
EPS Next 3Y21.76%
ACA Yearly Income VS Free CF VS DividendACA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ACA Dividend Payout.ACA Dividend Payout, showing the Payout Ratio.ACA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ARCOSA INC

NYSE:ACA (2/13/2026, 8:04:00 PM)

After market: 127.47 0 (0%)

127.47

+0.75 (+0.59%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)10-30
Earnings (Next)02-26
Inst Owners94.81%
Inst Owner Change-3.24%
Ins Owners1.8%
Ins Owner Change0%
Market Cap6.25B
Revenue(TTM)2.83B
Net Income(TTM)148.60M
Analysts86
Price Target126.28 (-0.93%)
Short Float %1.85%
Short Ratio4.11
Dividend
Industry RankSector Rank
Dividend Yield 0.16%
Yearly Dividend0.2
Dividend Growth(5Y)-0.48%
DP6.66%
Div Incr Years0
Div Non Decr Years5
Ex-Date01-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.63%
Min EPS beat(2)15.61%
Max EPS beat(2)17.65%
EPS beat(4)3
Avg EPS beat(4)38.79%
Min EPS beat(4)-40.32%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)30.62%
EPS beat(12)11
Avg EPS beat(12)32.12%
EPS beat(16)15
Avg EPS beat(16)40.53%
Revenue beat(2)1
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)11
Avg Revenue beat(16)1.99%
PT rev (1m)3.34%
PT rev (3m)6.72%
EPS NQ rev (1m)-1.44%
EPS NQ rev (3m)1.71%
EPS NY rev (1m)0.29%
EPS NY rev (3m)4.09%
Revenue NQ rev (1m)-0.29%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)0.17%
Valuation
Industry RankSector Rank
PE 33.72
Fwd PE 26.43
P/S 2.21
P/FCF 19.87
P/OCF 13.32
P/B 2.42
P/tB 6.81
EV/EBITDA 14.72
EPS(TTM)3.78
EY2.97%
EPS(NY)4.82
Fwd EY3.78%
FCF(TTM)6.41
FCFY5.03%
OCF(TTM)9.57
OCFY7.51%
SpS57.76
BVpS52.7
TBVpS18.72
PEG (NY)0.81
PEG (5Y)6.53
Graham Number66.95
Profitability
Industry RankSector Rank
ROA 2.94%
ROE 5.75%
ROCE 6.5%
ROIC 4.99%
ROICexc 5.24%
ROICexgc 8.62%
OM 10.27%
PM (TTM) 5.25%
GM 21.61%
FCFM 11.11%
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ROICexc(3y)4.17%
ROICexc(5y)4.21%
ROICexgc(3y)7.17%
ROICexgc(5y)7.33%
ROCE(3y)5.21%
ROCE(5y)5.27%
ROICexgc growth 3Y4.01%
ROICexgc growth 5Y-10.09%
ROICexc growth 3Y4.98%
ROICexc growth 5Y-11.63%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.03
Debt/EBITDA 3.04
Cap/Depr 68.36%
Cap/Sales 5.46%
Interest Coverage 250
Cash Conversion 90.74%
Profit Quality 211.71%
Current Ratio 2.02
Quick Ratio 1.3
Altman-Z 2.66
F-Score5
WACC9.22%
ROIC/WACC0.54
Cap/Depr(3y)104.81%
Cap/Depr(5y)89.02%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.15%
Profit Quality(3y)128.08%
Profit Quality(5y)133.99%
High Growth Momentum
Growth
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
EPS Next Y41.62%
EPS Next 2Y26.58%
EPS Next 3Y21.76%
EPS Next 5YN/A
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
Revenue Next Year10.81%
Revenue Next 2Y8.17%
Revenue Next 3Y7.15%
Revenue Next 5YN/A
EBIT growth 1Y48.65%
EBIT growth 3Y20.99%
EBIT growth 5Y5.01%
EBIT Next Year135.94%
EBIT Next 3Y39.06%
EBIT Next 5YN/A
FCF growth 1Y5015.62%
FCF growth 3Y56.55%
FCF growth 5Y2.7%
OCF growth 1Y146.35%
OCF growth 3Y44.47%
OCF growth 5Y6.95%

ARCOSA INC / ACA FAQ

Can you provide the ChartMill fundamental rating for ARCOSA INC?

ChartMill assigns a fundamental rating of 5 / 10 to ACA.


Can you provide the valuation status for ARCOSA INC?

ChartMill assigns a valuation rating of 4 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.


How profitable is ARCOSA INC (ACA) stock?

ARCOSA INC (ACA) has a profitability rating of 5 / 10.


What is the valuation of ARCOSA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 33.72 and the Price/Book (PB) ratio is 2.42.


How financially healthy is ARCOSA INC?

The financial health rating of ARCOSA INC (ACA) is 5 / 10.